Helmy Eltoukhy and AmirAli Talasaz
Courtesy of Guardant Health
- Age38, 38
- TitleCofounder and CEO; Cofounder and president
- CompanyGuardant Health
Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related biological markers. The method has drawn plenty of interest -- and capital -- despite initial skepticism. Guardant raised $360 million in May, and aims to sequence more than 1 million cancer patients' DNA within five years.
40 Under 40